Long Focus Capital Management, LLC Iovance Biotherapeutics, Inc. Transaction History
Long Focus Capital Management, LLC
- $2.17 Billion
- Q2 2025
A detailed history of Long Focus Capital Management, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 11,820,000 shares of IOVA stock, worth $26.8 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
11,820,000
Previous 9,250,055
27.78%
Holding current value
$26.8 Million
Previous $30.8 Million
34.0%
% of portfolio
0.94%
Previous 1.07%
Shares
16 transactions
Others Institutions Holding IOVA
# of Institutions
287Shares Held
233MCall Options Held
1.12MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$65.8 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$56.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$48.2 Million0.0% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny9.33MShares$21.2 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $358M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...